UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity

Scientific reports, 2021-06, Vol.11 (1), p.11676-11676, Article 11676

2021

Link zum Volltext

Verfügbarkeit prüfen

Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia

Cancers, 2022-01, Vol.14 (3), p.663

2022

Link zum Volltext

Verfügbarkeit prüfen

Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival

Oncotarget, 2015-12, Vol.6 (39), p.42130-42149

2015

Link zum Volltext

Verfügbarkeit prüfen

Hedgehog activation in CLL

Blood, 2019-06, Vol.133 (25), p.2628-2630

2019

Link zum Volltext

Verfügbarkeit prüfen

Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL

Blood, 2020-12, Vol.136 (25), p.2918-2926

2020

Link zum Volltext

Verfügbarkeit prüfen

DC-SIGN Binding to the Oligomannose-Type Glycans on the Surface Immunoglobulin Variable Region of Follicular Lymphoma Promotes Selective Adhesion to Microenvironmental VCAM-1

Blood, 2022-11, Vol.140 (Supplement 1), p.6460-6461

2022

Link zum Volltext

Verfügbarkeit prüfen

Lymphoma-Specific Subversion of B-Cell Receptor Signaling By Macrophage Lectins

Blood, 2018-11, Vol.132 (Supplement 1), p.2865-2865

2018

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients

Clinical cancer research, 2019-04, Vol.25 (8), p.2503-2512

2019

Link zum Volltext

Verfügbarkeit prüfen

Acquisition of Mannoses on the Surface Immunoglobulin Binding Site Reveals Functional Status and Cell of Origin in Diffuse Large B Cell Lymphomas

Blood, 2018-11, Vol.132 (Supplement 1), p.677-677

2018

Link zum Volltext

Verfügbarkeit prüfen

Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells

British journal of haematology, 2017-07, Vol.178 (1), p.81-93

2017

Link zum Volltext

Verfügbarkeit prüfen

Mannosylation of the Tumor Immunoglobulin Variable Region Informs Cell of Origin and Environmental Interactions in DLBCL Subsets

Blood, 2019-11, Vol.134 (Supplement_1), p.1505-1505

2019

Link zum Volltext

Verfügbarkeit prüfen

Early Enhancement of IgM Expression and Signaling Capacity during Ibrutinib Therapy in CLL Patients

Blood, 2016-12, Vol.128 (22), p.4381-4381

2016

Link zum Volltext

Verfügbarkeit prüfen

Cortactin Is a New Player in Aggressiveness and Diffusion of Chronic Lymphocytic Leukaemia

Blood, 2016-12, Vol.128 (22), p.4353-4353

2016

Link zum Volltext

Verfügbarkeit prüfen

Expression of FAK and Its Involvement in the Progression of B-Cell Chronic Lymphocytic Leukemia

Blood, 2014-12, Vol.124 (21), p.3309-3309

2014

Link zum Volltext

Verfügbarkeit prüfen

Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2015-10, Vol.15 (10), p.612-620.e5

2015

Link zum Volltext

Verfügbarkeit prüfen

High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL

Blood advances, 2022-09, Vol.6 (18), p.5494-5504

2022

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide promoter methylation of hairy cell leukemia

Blood advances, 2019-02, Vol.3 (3), p.384-396

2019

Link zum Volltext

Verfügbarkeit prüfen

International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019-09, Vol.19, p.S278-S278

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Humans
(10)
Hematology
(7)
Adenine - Analogs & Derivatives
(4)
Female
(4)
Immunoglobulin M
(4)
Leukemia, Lymphocytic, Chronic, B-Cell - Metabolism
(4)
Leukemia, Lymphocytic, Chronic, B-Cell - Pathology
(4)
Male
(4)
Medicin Och Hälsovetenskap
(4)
Oncology
(4)
Aged
(3)
Chronic Lymphocytic Leukemia
(3)
Lymphocytes B
(3)
Middle Aged
(3)
Piperidines
(3)
Signal Transduction
(3)
Adult
(2)
Aged, 80 And Over
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(11)
Blood Advances
(2)
Clinical Lymphoma, Myeloma And Leukemia
(2)
Frontiers In Pediatrics
(2)
British Journal Of Haematology
(1)
Cancers
(1)
Clinical Cancer Research
(1)
Clinical Lymphoma Myeloma & Leukemia
(1)
Hemasphere
(1)
Oncotarget
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity

Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia

Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival

S142: FOXO1‐RICTOR AXIS INDUCES ADAPTIVE INCREASE IN AKT ACTIVITY DURING BCR INHIBITOR THERAPY IN CLL: IMPLICATIONS FOR COMBINATION THERAPY

Hedgehog activation in CLL

Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL

DC-SIGN Binding to the Oligomannose-Type Glycans on the Surface Immunoglobulin Variable Region of Follicular Lymphoma Promotes Selective Adhesion to Microenvironmental VCAM-1

Lymphoma-Specific Subversion of B-Cell Receptor Signaling By Macrophage Lectins

Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients

Acquisition of Mannoses on the Surface Immunoglobulin Binding Site Reveals Functional Status and Cell of Origin in Diffuse Large B Cell Lymphomas

Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior

Mannosylation of the Tumor Immunoglobulin Variable Region Informs Cell of Origin and Environmental Interactions in DLBCL Subsets

High Surface IgM Levels Associate with Shorter Response Duration and Bypass of the BTK Blockade during Ibrutinib Therapy in CLL Patients

Early Enhancement of IgM Expression and Signaling Capacity during Ibrutinib Therapy in CLL Patients

Cortactin Is a New Player in Aggressiveness and Diffusion of Chronic Lymphocytic Leukaemia

Expression of FAK and Its Involvement in the Progression of B-Cell Chronic Lymphocytic Leukemia

Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia

High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL

Genome-wide promoter methylation of hairy cell leukemia

International Prognostic Score (IPS-A) for Patients with Early Stage Chronic Lymphocytic Leukemia

Corrigendum: The new Italian registry of infantile thrombosis (RITI): a reflection on its journey, challenges and pitfalls

The new Italian registry of infantile thrombosis (RITI): A reflection on its journey, challenges and pitfalls

Suchergebnisse filtern